2,587 Danaher Corporation $DHR Shares Purchased by RFG Bristol Wealth Advisors LLC

RFG Bristol Wealth Advisors LLC boosted its position in Danaher Corporation (NYSE:DHR) by 215.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,790 shares of the conglomerate’s stock after buying an additional 2,587 shares during the period. RFG Bristol Wealth Advisors LLC’s holdings in Danaher were worth $840,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Danaher in the 2nd quarter worth $10,492,520,000. State Street Corp increased its stake in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after acquiring an additional 472,608 shares during the period. Wellington Management Group LLP increased its stake in shares of Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock worth $3,108,031,000 after acquiring an additional 1,542,310 shares during the period. Jupiter Topco LLC purchased a new position in Danaher during the second quarter worth about $1,456,317,000. Finally, Generation Investment Management LLP acquired a new stake in Danaher in the second quarter valued at about $1,287,949,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

DHR stock opened at $220.15 on Friday. The firm has a 50 day moving average of $211.38 and a 200-day moving average of $194.62. The company has a market cap of $154.76 billion, a price-to-earnings ratio of 39.10, a PEG ratio of 2.71 and a beta of 0.76. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 EPS. The company’s revenue was up 5.5% compared to the same quarter last year. As a group, equities analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio is 28.42%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. The Goldman Sachs Group lifted their price objective on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a report on Monday, September 21st. Stifel Nicolaus reduced their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. UBS Group began coverage on Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price objective on the stock. Finally, Royal Bank Of Canada increased their price objective on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research report on Monday. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $235.23.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.